A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients
To compare the effectiveness of KRN321 to placebo in the treatment of anemia in cancer patients receiving multi cycle platinum-containing chemotherapy
Anemia
DRUG: darbepoetin alfa
To compare the proportion of subjects who reach red blood cell transfusion trigger
To compare the effectiveness of KRN321 on the proportion of subjects achieving hemoglobin response|To compare the proportion of subjects who receive red blood cell transfusions|To compare the effectiveness of KRN321 based on quality of life scores
To compare the effectiveness of KRN321 to placebo in the treatment of anemia in cancer patients receiving multi cycle platinum-containing chemotherapy